Packagers Pursue Sustainability - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Packagers Pursue Sustainability
Nonpharmaceutical manufacturers find ways to make environmentally sound packaging.


Pharmaceutical Technology


As a result, flexible packaging, which can save as much as 80% in weight, has a clear advantage over rigid packaging (1). Another source-reduction strategy includes putting concentrated products in smaller containers. Larger sizes are being embraced by makers of laundry detergent such as Procter & Gamble (Cincinnati, OH) and Unilever United States (Englewood Cliffs, NJ), which have introduced products that wash the same number of loads with one-half or one-third of the liquid used previously. "For packaging designers and decision makers ... the product-to-package weight ratio is an excellent topline indicator for making decisions about packaging efficiency and sustainability," says Bob Lilienfeld, editor of The Use Less Stuff Report.

It's also possible to lighten rigid containers. The beverage industry and its packaging suppliers are using state-of-the-art technology in process simulation, mold design, molding, and material innovations to reduce the weight of its containers and closures without affecting its high-speed filling lines.

Nestle Waters North America (Greenwich, CT), for example, is rolling out what it claims is the lightest half-liter polyethylene terephthalate (PET) water bottle in production ("Eco-Shape" container). At 12.5 g, the container weighs about 30% less than other water bottles. Ozarka Natural Spring Water launched the design in August 2007, but it eventually will be used across other sizes and other Nestle Waters brands such as Arrowhead. The lighter bottle uses a smaller label, but retains the 26.7-mm closure of its predecessor. The lightweight container must be handled more gently, especially when empty. In some cases, it requires fine-tuning of multipack specifications. In market tests, consumers responded positively to the container and liked it even better after they learned it is better for the environment.

For carbonated soft drinks, Coca-Cola (Atlanta, GA) introduced an updated design for its 20-oz contour PET bottle. The design reduces container weight by 5% while improving ergonomics with textured gripping areas. Weight savings is accomplished primarily by changes in the neck finish to accommodate a short-skirt cap.


Shortening the closure skirt removes material from both the closure and the neck finish of the container. (PHOTO: ALCOA CSI)
Container-weight reduction often goes hand in hand with closure-weight reduction. The short-skirt closures coming on the market in the beverage industry not only weigh less than standard caps, but also allow bottle designers to use less material in the finish area of the bottle. The combined weight savings can total as much as 2 g/container ("Xtra-Lok" mini closure for carbonated soft drinks, "MB-Lok" mini closure for cold-filled malt beverages, Alcoa Closure Systems International, Indianapolis, IN).

The short-skirt closures typically require changes in the capping process, but cap suppliers are prepared to assist in the transition ("capper conversion kit," Alcoa CSI).


Nestable design requires less material per cap plus helps closures maintain their shape. (PHOTO: INNOVATIVE MOLDING)
One way to reduce cap weight is to design the closure to stack so that the top part of one cap supports the skirt bottom of the next. The resulting nested "logs" of closures retain their shape better. With as many as 60% more closures per corrugated shipper, the nested closures reduce packaging, lower freight costs, and minimize the time filling-line operators spend replenishing supplies. Currently available in 63-, 89- and 110- mm sizes, the closures are compatible with liquid and dry pharmaceuticals, and ambient and hot filling ("TaperStack" closures, Innovative Molding, Sebastopol, CA).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
24%
Oversee medical treatment of patients in the US.
12%
Provide treatment for patients globally.
10%
All of the above.
44%
No government involvement in patient treatment or drug development.
10%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Source: Pharmaceutical Technology,
Click here